Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Geron (GERN)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for GERN as compared to
Top Competitors
Drug Manufacturers - Other
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
1.12M
LOW
EBITDA
►
-50.5M
AVG
Net Income
►
-52.0M
AVG
Revenue Growth
►
-83.9%
LOW
Operating Margin
►
-4576.1%
VERY LOW
Net Margin
►
-4620.3%
VERY LOW
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.0540
VERY LOW
Current Ratio
►
19.7
VERY HIGH
Quick Ratio
►
19.7
VERY HIGH
Interest Coverage Ratio
►
-445
LOW
Book Value Per Share
►
2.06
Cash Per Share
►
1.11
Loading...
STOCK SUMMARY
Open
5.29
Day Range
5.26
-
5.43
52 Week Range
3.00
-
9.24
Volume
1.36M
Avg Volume (3 mo)
1.28M
Shares Outstanding
94.1M
Market Cap
488M
VALUATION
Price to Earnings (P/E)
►
-9.73
Price to Book (P/B)
►
2.75
AVG
Price to Sales (P/S)
►
450
VERY HIGH
Return on Assets (ROA)
►
-27.2%
AVG
Return on Equity (ROE)
►
-28.7%
AVG
EV/EBITDA
►
-11.9
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
-4.6%
Held by insiders
6.5%
Held by institutions
18.2%
No Sales Breakout Data.